Treating early-stage centrally-located non-small cell lung cancer with DCAT-SBRT in centers lacking the VMAT technique: a comprehensive study
2024

Using DCAT for Lung Cancer Treatment

Sample size: 36 publication 10 minutes Evidence: high

Author Information

Author(s): Huang Yangyang, Yang Jun, Song Rui, Qin Tingting, Yang Menglin, Liu Yibao

Primary Institution: East China University of Technology

Hypothesis

Is the DCAT technique a better option for treating early-stage centrally-located non-small cell lung cancer in centers without VMAT?

Conclusion

The DCAT technique provides better treatment efficiency and delivery accuracy for early-stage centrally-located NSCLC patients compared to other techniques.

Supporting Evidence

  • The DCAT technique showed significant reductions in plan complexity and delivery time.
  • DCAT plans had higher γ-passing rates compared to IMRT plans.
  • The mean dose difference in DCAT plans did not exceed 3% at expected respiratory amplitudes.
  • DCAT plans provided better OAR-sparing compared to 3DCRT.

Takeaway

Doctors found that a special way of giving radiation called DCAT works better for some lung cancer patients than other methods.

Methodology

The study involved 36 patients treated with SBRT using the DCAT technique, comparing it with 3DCRT and IMRT techniques.

Limitations

The study does not address the treatment of multiple lesions or larger PTV volumes.

Participant Demographics

{"age_range":"32 to 73 years","median_age":51,"gender_distribution":{"males":19,"females":17},"tumor_stage":{"T1N0M0":14,"T2N0M0":22}}

Statistical Information

P-Value

p<0.001

Confidence Interval

95%

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3389/fonc.2024.1431082

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication